Title:
DETECTION AND TREATMENT OF MICROSPORIDIAN INFECTION
Document Type and Number:
WIPO Patent Application WO/2018/051071
Kind Code:
A9
Abstract:
An isolated or synthetic nucleic acid from having a sequence selected from the group consisting of SEQ ID NOs: 9, 13 and 1-8, or a homologues thereof, an isolated or synthetic nucleic acid complementary to a sequence selected from the group consisting of SEQ ID NOs: 1-14, or a homologues thereof, an isolated polypeptide encoded by the nucleic acid, or an antibody that binds thereto, may be used as an immunogenic composition or diagnostic, or in a method of treatment or prevention, in respect of a microsporidian infection, in particular a Tetramicra brevifilum infection in animals, particularly fish. Additionally, methods of testing an agent for the prevention and/or treatment of a microsporidian infection, preferably a Tetramicra brevifilum infection, and kits for screening for a microsporidian infection, are provided.
Inventors:
SCHOLZ FELIX (IE)
RODGER HAMISH (IE)
RODGER HAMISH (IE)
Application Number:
PCT/GB2017/052676
Publication Date:
April 19, 2018
Filing Date:
September 12, 2017
Export Citation:
Assignee:
BENCHMARK ANIMAL HEALTH LTD (GB)
International Classes:
A61K39/395; C12N15/11; C12Q1/68; G01N33/53
Attorney, Agent or Firm:
MITCHELL, Simon (GB)
Download PDF: